TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

Abstract

Spinal cord injury (SCI) often causes long-term disability. But effective means to promote proper regeneration after SCI has so far failed to reach the clinic. Here, we report that fibrotic scar formation at injury sites prevents recovery after SCI and that the inhibition of fibrotic scar formation significantly improved SCI recovery in adult mice. We found that after SCI there is an elevation of macrophages, which are a primary source of activated transforming growth factor-β 1 (TGF-β1) that in turn recruits mesenchymal stromal/stem cells (MSCs) to induce their fibroblast differentiation, thus promoting scar formation. We also found that activated TGF-β1 acts on resident pericytes in the endothelial niche of the blood-spinal cord barrier to promote their differentiation into fibroblasts, which also contributes to scarring. Interrupting these pathways by selective genetic KOs or treatment with a TGF-β–neutralizing antibody inhibited scar formation and improved SCI functional recovery. Notably, we found that neonatal mice recover scarlessly after SCI and with no active TGF-β at the injury site. Together, these findings suggest that fibrotic scarring occurs due to elevated activation of TGF-β, and preventing such activation or neutralizing active TGF-β may be an approach to improve outcome after SCI.

References

[1] McDonald JW, Sadowsky C. Spinal-cord injury. Lancet. 2002, 359: 417-425.

[2] Holmes D. Spinal-cord injury: spurring regrowth. Nature. 2017, 552: S49.

[3] Spinal cord injury facts and figures at a glance. J. Spinal Cord. Med.37, 117−118 (2014).

[4] Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci.. 2006, 7628-643.

[5] Zhu Yet al. . Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury. Neurobiol. Dis.. 2015, 74: 114-125.

[6] Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J. Clin. Investig.. 2012, 122: 3824-3834.

[7] Anderson MAet al. . Astrocyte scar formation aids central nervous system axon regeneration. Nature. 2016, 532: 195-200.

[8] Dias DO, Goritz C. Fibrotic scarring following lesions to the central nervous system. Matrix Biol.. 2018, 68-69: 561-570.

[9] Courtine G, Sofroniew MV. Spinal cord repair: advances in biology and technology. Nat. Med.. 2019, 25: 898-908.

[10] Tang X, Davies JE, Davies SJ. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res.. 2003, 71: 427-444.

[11] Braga TT, Agudelo JS, Camara NO. Macrophages during the fibrotic process: M2 as friend and foe. Front. Immunol.. 2015, 6: 602.

[12] Perrin FE, Lacroix S, Aviles-Trigueros M, David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain. 2005, 128854-866.

[13] Kigerl KAet al. . Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci.. 2009, 29: 13435-13444.

[14] Zhou Xet al. . Microglia and macrophages promote corralling, wound compaction and recovery after spinal cord injury via Plexin-B2. Nat. Neurosci.. 2020, 23: 337-350.

[15] Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol.. 2008, 173: 1617-1627.

[16] Hines DJ, Hines RM, Mulligan SJ, Macvicar BA. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia. 2009, 57: 1610-1618.

[17] Hara Met al. . Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury. Nat. Med.. 2017, 23: 818-828.

[18] Xu Bet al. . Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury. Neurobiol. Dis.. 2015, 73: 36-48.

[19] Goritz Cet al. . A pericyte origin of spinal cord scar tissue. Science. 2011, 333: 238-242.

[20] Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009, 326: 1216-1219.

[21] Distler JHWet al. . Shared and distinct mechanisms of fibrosis. Nat. Rev. Rheumatol.. 2019, 15: 705-730.

[22] Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal. 2008, 20: 1409-1414.

[23] Wilson SE, Marino GK, Torricelli AAM, Medeiros CS. Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: a paradigm for fibrosis in other organs?. Matrix Biol.. 2017, 64: 17-26.

[24] Tang Yet al. . TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med.. 2009, 15: 757-765.

[25] Wan Met al. . Injury-activated transforming growth factor beta controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells. 2012, 30: 2498-2511.

[26] Wang Xet al. . Inhibition of overactive TGF-beta attenuates progression of heterotopic ossification in mice. Nat. Commun.. 2018, 9. 551

[27] Zhen Get al. . Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med.. 2013, 19: 704-712.

[28] Zhen Get al. . Mechanical stress determines the configuration of TGFbeta activation in articular cartilage. Nat. Commun.. 2021, 12. 1706

[29] Flanders KC, Ren RF, Lippa CF. Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol.. 1998, 54: 71-85.

[30] Di Gregorio Jet al. . The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders. Front. Cell Dev. Biol.. 2020, 8. 607483

[31] El Agha Eet al. . Mesenchymal stem cells in fibrotic disease. Cell Stem Cell. 2017, 21: 166-177.

[32] Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int.. 2014, 2014. 340257

[33] Li Yet al. . Microglia-organized scar-free spinal cord repair in neonatal mice. Nature. 2020, 587: 613-618.

[34] Inman D, Guth L, Steward O. Genetic influences on sary degeneration and wound healing following spinal cord injury in various strains of mice. J. Comp. Neurol.. 2002, 451: 225-235.

[35] Antri M, Orsal D, Barthe JY. Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist. Eur. J. Neurosci.. 2002, 16: 467-476.

[36] Musienko Pet al. . Controlling specific locomotor behaviors through multidimensional monoaminergic modulation of spinal circuitries. J. Neurosci.. 2011, 31: 9264-9278.

[37] Slawinska U, Miazga K, Jordan LM. The role of serotonin in the control of locomotor movements and strategies for restoring locomotion after spinal cord injury. Acta Neurobiol. Exp.. 2014, 74: 172-187.

[38] Ahn MJ, Cho GW. Metformin promotes neuronal differentiation and neurite outgrowth through AMPK activation in human bone marrow-mesenchymal stem cells. Biotechnol. Appl. Biochem.. 2017, 64: 836-842.

[39] Hu Set al. . Substantial neuroprotective and neurite outgrowth-promoting activities by bis(propyl)-cognitin via the activation of Alpha7-nAChR, a promising anti-Alzheimer’s Dimer. ACS Chem. Neurosci.. 2015, 6: 1536-1545.

[40] Basso DMet al. . Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma. 2006, 23: 635-659.

[41] Pohlers Det al. . TGF-beta and fibrosis in different organs–molecular pathway imprints. Biochim. Biophys. Acta. 2009, 1792: 746-756.

[42] Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H. Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-beta Signaling. Front. Cardiovasc. Med.. 2020, 7: 34.

[43] Garcia Jet al. . Tie1 deficiency induces endothelial-mesenchymal transition. EMBO Rep.. 2012, 13431-439.

[44] Pinto MT, Covas DT, Kashima S, Rodrigues CO. Endothelial mesenchymal transition: comparative analysis of different induction methods. Biol. Proced. Online. 2016, 18. 10

[45] Bansal R, van Baarlen J, Storm G, Prakash J. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. Sci. Rep.. 2015, 5. 18272

[46] Bloom O. Non-mammalian model systems for studying neuro-immune interactions after spinal cord injury. Exp. Neurol.. 2014, 258: 130-140.

[47] Lee-Liu D, Edwards-Faret G, Tapia VS, Larrain J. Spinal cord regeneration: lessons for mammals from non-mammalian vertebrates. Genesis. 2013, 51: 529-544.

[48] Zhang Z, Li F, Sun T. Does repair of spinal cord injury follow the evolutionary theory?. Neural Regen. Res. 2012, 7: 849-852

[49] Fernandez-Klett F, Priller J. The fibrotic scar in neurological disorders. Brain Pathol.. 2014, 24: 404-413.

[50] Hellal Fet al. . Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science. 2011, 331: 928-931.

[51] Li Yet al. . RNAi-mediated ephrin-B2 silencing attenuates astroglial-fibrotic scar formation and improves spinal cord axon growth. CNS Neurosci. Ther.. 2017, 23: 779-789.

[52] Tran AP, Warren PM, Silver J. The biology of regeneration failure and success after spinal cord injury. Physiol. Rev.. 2018, 98: 881-917.

[53] Wanner IBet al. . Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci.. 2013, 33: 12870-12886.

[54] Alizadeh Aet al. . Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia. 2017, 65: 1152-1175.

[55] Li L, Ni L, Eugenin EA, Heary RF, Elkabes S. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury. Brain Behav. Immun.. 2019, 80: 328-343.

[56] Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci.. 2009, 10: 235-241.

[57] Seo TB, Chang IA, Lee JH, Namgung U. Beneficial function of cell division cycle 2 activity in astrocytes on axonal regeneration after spinal cord injury. J. Neurotrauma. 2013, 30: 1053-1061.

[58] White REet al. . Transforming growth factor alpha transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J. Neurosci.. 2011, 31: 15173-15187.

[59] Cooper JGet al. . Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury. Neurobiol. Dis.. 2018, 116: 60-68.

[60] Soderblom Cet al. . Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury. J. Neurosci.. 2013, 33: 13882-13887.

[61] Zhou Tet al. . Microvascular endothelial cells engulf myelin debris and promote macrophage recruitment and fibrosis after neural injury. Nat. Neurosci.. 2019, 22: 421-435.

[62] Voisin Aet al. . Differential expression and localisation of TGF-beta isoforms and receptors in the murine epididymis. Sci. Rep.. 2020, 10. 995

[63] Xu Xet al. . Transforming growth factor-beta in stem cells and tissue homeostasis. Bone Res.. 2018, 6: 2.

[64] Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J. Clin.. 2014, 124466-472

[65] Hinz B. The extracellular matrix and transforming growth factor-beta1: Tale of a strained relationship. Matrix Biol.. 2015, 47: 54-65.

[66] Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-beta - an excellent servant but a bad master. J. Transl. Med.. 2012, 10. 183

[67] MacFarlane EG, Haupt J, Dietz HC, Shore EM. TGF-beta family signaling in connective tissue and skeletal diseases. Cold Spring Harb Perspect Biol. 2017, 9: a022269.

[68] Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer. 2003, 3807-821.

[69] Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29: 117-129.

[70] Massague J. TGFbeta in cancer. Cell. 2008, 134: 215-230.

[71] Wang Wet al. . MicroRNA-21-5p mediates TGF-beta-regulated fibrogenic activation of spinal fibroblasts and the formation of fibrotic scars after spinal cord injury. Int. J. Biol. Sci.. 2018, 14: 178-188.

[72] Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N. Engl. J. Med.. 2000, 342: 1350-1358.

[73] Kim KK, Sheppard D, Chapman HA. TGF-beta1 signaling and tissue fibrosis. Cold Spring Harb. Perspect. Biol. 2018, 10: a022293.

[74] Liu Ret al. . microRNA-21 regulates astrocytic reaction post-acute phase of spinal cord injury through modulating TGF-beta signaling. Aging. 2018, 101474-1488.

[75] Song Get al. . TGF-beta secretion by M2 macrophages induces glial scar formation by activating astrocytes in vitro. J. Mol. Neurosci.. 2019, 69: 324-332.

[76] Fang Set al. . Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-beta/SMAD2 pathway during wound healing. Stem Cells Transl. Med. 2016, 5: 1425-1439.

[77] Shi Let al. . Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-beta signaling inhibition. Stem Cell Res. Ther.. 2021, 12: 230.

[78] Deng Zet al. . TGF-beta signaling in health, disease, and therapeutics. Signal Transduct. Target Ther.. 2024, 961.

[79] Patel NKet al. . Macrophage TGF-beta signaling is critical for wound healing with heterotopic ossification after trauma. JCI Insight. 2022, 7e144925.

[80] Wang Let al. . Transforming growth factor beta plays an important role in enhancing wound healing by topical application of Povidone-iodine. Sci. Rep.. 2017, 7. 991

[81] Damisah ECet al. . Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci. Adv.. 2020, 6. eaba3239

[82] Sen MK, Mahns DA, Coorssen JR, Shortland PJ. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis. Glia. 2022, 701215-1250.

[83] Armulik Aet al. . Pericytes regulate the blood-brain barrier. Nature. 2010, 468: 557-561.

[84] Dias DOet al. . Reducing pericyte-derived scarring promotes recovery after spinal cord injury. Cell. 2018, 173: 153-165 e122.

[85] Li Yet al. . Pericytes impair capillary blood flow and motor function after chronic spinal cord injury. Nat. Med.. 2017, 23: 733-741.

[86] Dorrier CE, Jones HE, Pintaric L, Siegenthaler JA, Daneman R. Emerging roles for CNS fibroblasts in health, injury and disease. Nat. Rev. Neurosci.. 2022, 23: 23-34.

[87] Cathery W, Faulkner A, Maselli D, Madeddu P. Concise review: the regenerative journey of pericytes toward clinical translation. Stem Cells. 2018, 36: 1295-1310.

[88] Laredo F, Plebanski J, Tedeschi A. Pericytes: Problems and Promises for CNS Repair. Front. Cell Neurosci.. 2019, 13: 546.

[89] Lu Yet al. . Bone mesenchymal stem cell-derived extracellular vesicles promote recovery following spinal cord injury via improvement of the integrity of the blood-spinal cord barrier. Front. Neurosci.. 2019, 13209.

[90] Li Zet al. . Fibrotic scar after spinal cord injury: crosstalk with other cells, cellular origin, function, and mechanism. Front. Cell Neurosci.. 2021, 15. 720938

[91] Tsivelekas Ket al. . Angiogenesis in spinal cord injury: progress and treatment. Cureus. 2022, 14e25475

[92] Cheng Jet al. . Targeting pericytes for therapeutic approaches to neurological disorders. Acta Neuropathol.. 2018, 136507-523.

[93] Tai Wet al. . In vivo reprogramming of NG2 glia enables adult neurogenesis and functional recovery following spinal cord injury. Cell Stem Cell. 2021, 28: 923-937.e924.

[94] Bellver-Landete Vet al. . Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury. Nat. Commun.. 2019, 10. 518

[95] Ying HZet al. . PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review). Mol. Med. Rep.. 2017, 16: 7879-7889.

[96] Irma Jet al. . From growth factors to structure: PDGF and TGF-beta in granulation tissue formation. a literature review. J. Cell Mol. Med.. 2025, 29. e70374

[97] Duncan MRet al. . Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J.. 1999, 13: 1774-1786.

[98] Tsai CC, Wu SB, Kau HC, Wei YH. Essential role of connective tissue growth factor (CTGF) in transforming growth factor-beta1 (TGF-beta1)-induced myofibroblast transdifferentiation from Graves’ orbital fibroblasts. Sci. Rep.. 2018, 8. 7276

[99] Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos.. 1991, 19: 36-43.

[100] Meletis Ket al. . Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol.. 2008, 6: e182.

[101] Chytil A, Magnuson MA, Wright CV, Moses HL. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis. 2002, 3273-75.

[102] Faulkner JRet al. . Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci.. 2004, 24: 2143-2155.

[103] Herrmann JEet al. . STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci.. 2008, 28: 7231-7243.

[104] Anderson MAet al. . Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature. 2018, 561: 396-400.

[105] Angeby-Moller K, Berge OG, Hamers FP. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib. J. Neurosci. Methods. 2008, 174: 1-9.

[106] Hamers FP, Koopmans GC, Joosten EA. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma. 2006, 23: 537-548.

[107] Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharm. Exp. Ther.. 1953, 107: 385-393.

[108] Zheng GXet al. . Massively parallel digital transcriptional profiling of single cells. Nat. Commun.. 2017, 8. 14049

[109] Hao Yet al. . Integrated analysis of multimodal single-cell data. Cell. 2021, 184: 3573-3587.e3529.

[110] Korsunsky Iet al. . Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 2019, 16: 1289-1296.

[111] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.. 2014, 15. 550

[112] Tan Y, Cahan P. SingleCellNet: a computational tool to classify single cell RNA-Seq data across platforms and across species. Cell Syst.. 2019, 9: 207-213.e202.

[113] Tabula Muris C. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature. 2020, 583: 590-595.

[114] Street Ket al. . Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018, 19. 477

[115] Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc.. 2020, 15: 1484-1506.

[116] Chen EYet al. . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma.. 2013, 14. 128

[117] Kuleshov MVet al. . Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res.. 2016, 44: W90-97.

Funding

U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)(P01AG066603)

RIGHTS & PERMISSIONS

The Author(s)